Research reveals GLP-1 receptor agonists influence gut microbiome, enhancing metabolic health and offering anti-inflammatory ...

Also, insulin resistance impairs lymphatic function and GLP-1 drugs are very effective for Type 2 diabetes, Dayan notes. He’s seen a good response with both semaglutide, the active ingredient in ...

In a pivotal year, GLP-1 competitors will vie for sites ... Once primarily viewed as a support function in healthcare, it now plays a central role in bridging the gap between research and clinical ...

The phase 2 ELAD study of Novo Nordisk's once-daily injectable GLP-1 agonist liraglutide in people ... but the improvements in brain volume and cognitive function were statistically significant.

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...

Beyond lowering blood sugar, GLP-1 medications have also been linked to a range of other benefits, including improved heart health, neurological function and metabolic health, as Fox News Digital ...

GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.

The research provides new insights into how headaches develop in raised intracranial pressure (ICP)-related conditions and suggest new treatments for patients.

In one study, once-daily danuglipron resulted in one patient who experienced drug-related elevated liver enzymes.

Pfizer has axed its oral GLP-1 asset danuglipron after one patient had potential drug-induced liver injury in a phase 1 trial ...